Zeyun Mi

7PUBLICATIONS
42CO-AUTHORS
Molecular targetsGenome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 18, 2026
DNA-PK-mediated CRTC2 phosphorylation promotes NHEJ and suppresses antitumor immunity via relocation to repair complexes.

|Apr 18, 2026
Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations.

|Aug 23, 2025
CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer.

Zhengkun Cai, Zeyuan Cheng, Lu Zhang

|Mar 04, 2025
CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance.

Meixi Wang, Fangdi Zou, Shengxin Wang

|Jun 28, 2024
MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB.

Yanchen Sun, Jing Wang, Minghan Qiu

|Jul 31, 2020
Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease.

Yi Lu, Yongzhan Sun, Zhiheng Liu

Pageof 2

Frequent Collaborators

4 joint publications

Zhiqiang Wu

3 joint publications

Zhiyong Yuan

3 joint publications

Kexin Chen

2 joint publications

Yupeng Chen